Veterinary Injectable Devices Market Size & Growth Forecast 2027–2036, By Segments (Usage, Animal Type, Material, Product, End Use, Clinical Applications), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Injectable Devices Market size was more than USD 1.01 Billion in 2026 and is set to grow at 5.29% CAGR between 2027 and 2036, exceeding USD 1.69 Billion by 2036. The industry revenue for 2027 is estimated at USD 1.05 Billion.
Get more details on this report
Request Free Sample ReportVeterinary Injectable Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 43.57% share in 2026, supported by advanced veterinary infrastructure, high animal-health awareness, and established adoption of specialized treatment technologies.
- Asia Pacific is projected to grow fastest as veterinary infrastructure, pet ownership, livestock healthcare investment, and demand for precise drug administration expand.
Segment Momentum
- Disposable devices captured 59.68% share in 2026 due to infection prevention benefits, reduced sterilization needs, and improved workflow efficiency in veterinary injection procedures.
- Companion animals held a 53.42% share in 2026 and are expanding fastest due to rising pet ownership, preventive healthcare demand, and increased veterinary treatment adoption.
Market Expansion Drivers
- Rising pet humanization increasing demand for advanced veterinary injectable delivery devices
- Expanding veterinary infrastructure in emerging markets improving animal healthcare access and treatment delivery
- Advancements in livestock vaccination programs driving precision injectable device adoption in animal health
Leading Market Participants
- Major companies in the veterinary injectable devices market include Zoetis Inc. (USA), Merck & Co., Inc. (USA), Elanco Animal Health Incorporated (USA), B. Braun Melsungen AG (Germany), Baxter International Inc. (USA), Terumo Corporation (Japan), Medtronic plc (Ireland), Neogen Corporation (USA), Henke-Sass, Wolf GmbH (Germany), Hamilton Company (USA)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.01 Billion
- 2027 Estimated Market Size: USD 1.05 Billion
- Projected Market Size: USD 1.69 Billion by 2036
- Growth Forecast: 5.29% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Disposable Devices (Usage) | Companion Animals (Animal Type) | Plastic (Material) | Syringes (Product) | Veterinary Hospitals (End Use) | Vaccination and Preventive Care (Clinical Applications)
- Emerging Opportunity Segment: Disposable Devices (Usage) | Companion Animals (Animal Type) | Plastic (Material) | Needle Free Injector Systems (Product) | Veterinary Clinics (End Use) | Vaccination and Preventive Care (Clinical Applications)
Market Growth Drivers and Industry Trends
Rising pet humanization increasing demand for advanced veterinary injectable delivery devices
Pet owners are increasingly treating companion animals as family members and are consequently more attentive to preventive care, diagnostics, chronic disease treatment, and procedural quality. This shift will drive veterinary injectable devices market growth as veterinarians adopt delivery technologies that support accurate dosing, safer administration, and improved handling during routine and specialized treatments. Advanced syringes, needles, auto-injectors, and other delivery formats can improve administration consistency while reducing discomfort and procedural complexity for animals and veterinary professionals. Greater willingness to invest in sophisticated veterinary care is also expanding demand for equipment suited to individualized treatment and recurring medication requirements.
Expanding veterinary infrastructure in emerging markets improving animal healthcare access and treatment delivery
Investment in veterinary clinics, diagnostic facilities, animal hospitals, and professional veterinary services is increasing access to structured animal healthcare across emerging markets. The veterinary injectable devices market will benefit as the expansion of treatment infrastructure creates new points of demand for syringes, needles, infusion systems, and other injectable delivery equipment used across companion-animal and livestock care. Improved availability of trained veterinary professionals also supports wider adoption of standardized administration practices and specialized treatment protocols. As healthcare access extends beyond major urban centers, demand for dependable injectable devices is broadening across a larger network of animal care facilities.
Advancements in livestock vaccination programs driving precision injectable device adoption in animal health
Livestock vaccination programs are becoming increasingly important for protecting animal populations from infectious diseases, maintaining herd health, and supporting the productivity of meat and dairy operations. In the veterinary injectable devices market, these programs are encouraging adoption of delivery equipment that can provide consistent dosing and efficient administration across large animal populations. Precision-oriented devices can help reduce medication waste, improve vaccination handling, and support standardized procedures in farms, veterinary facilities, and organized animal health programs. The growing focus on preventive livestock healthcare is consequently increasing the need for reliable injectable technologies capable of meeting high-volume treatment requirements.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pet humanization increasing demand for advanced veterinary injectable delivery devices | 1.8% | Moderate | North America, Europe | High | Near Term |
| Expanding veterinary infrastructure in emerging markets improving animal healthcare access and treatment delivery | 1.6% | Moderate | Asia Pacific, Latin America | Medium | Mid Term |
| Advancements in livestock vaccination programs driving precision injectable device adoption in animal health | 1.9% | Moderate | Asia Pacific, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the veterinary injectable devices market in 2026 with a share of 43.57%. The region benefits from advanced veterinary healthcare infrastructure, high awareness of animal health, and widespread adoption of specialized diagnostic and treatment technologies. Growing expenditure on companion animal healthcare, alongside established livestock and veterinary service networks, supports demand for reliable injectable devices used in routine treatments, vaccinations, and therapeutic procedures. Continued technological development in veterinary equipment and increasing emphasis on efficient and accurate drug administration are also contributing to the region's strong market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to witness the fastest growth, supported by expanding veterinary healthcare infrastructure, increasing pet ownership, and greater awareness of animal health and preventive care. Rising investment in livestock health is also encouraging the use of modern veterinary devices across agricultural and animal production systems. As veterinary practices become more sophisticated and access to professional animal healthcare improves, demand for convenient and precise injectable delivery technologies is expected to increase. Growing urbanization and changing attitudes toward companion animal care further strengthen the region's adoption potential.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Companion Care InnovationThe U.S. veterinary injectable devices market is supported by increasing demand for advanced drug delivery solutions across companion animal and livestock care. Manufacturers prioritize ergonomic injection systems, safety-engineered devices, and precision dosing technologies that improve treatment efficiency for veterinary professionals.
Germany 🇩🇪
Livestock Treatment EfficiencyGermany emphasizes veterinary injectable devices that improve livestock health management and regulatory compliance. Veterinary practices and animal health companies increasingly adopt durable, accurate injection systems designed to enhance biosecurity, vaccination programs, and production efficiency.
Japan 🇯🇵
Precision Animal HealthcareJapan advances the veterinary injectable devices market through demand for precise, minimally invasive treatment solutions. Veterinary clinics increasingly adopt high-quality injection devices that support companion animal care, specialty therapeutics, and efficient medication administration.
South Korea 🇰🇷
Modern Veterinary PracticeSouth Korea is strengthening veterinary injectable device adoption through expanding companion animal healthcare services and advanced livestock management. Local demand favors user-friendly injection technologies that improve treatment consistency, clinical workflow, and animal welfare outcomes.
France 🇫🇷
Preventive Care SupportFrance prioritizes veterinary injectable devices for preventive healthcare, vaccination programs, and herd management. Animal health providers increasingly seek reliable injection technologies that enhance treatment accuracy while supporting evolving veterinary practice standards.
Italy 🇮🇹
Clinical Equipment ModernizationItaly continues modernizing veterinary practices with injectable devices designed for efficient medication delivery and improved clinical safety. Demand is expanding across companion animal and agricultural sectors where dependable administration systems support routine treatment protocols.
Segment Leadership and Growth Trends
Veterinary Injectable Devices Market Share (%), by Usage, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportUsage Segment Analysis: Disposable Devices (Largest & Fastest-Growing Segment)
The veterinary injectable devices market was led by the disposable devices segment, which accounted for a 59.68% share in 2026, while also emerging as the fastest-growing segment. Its leadership is supported by the increasing emphasis on infection prevention, single-use safety protocols, and operational efficiency across veterinary practices. Disposable devices minimize the risk of cross-contamination, reduce sterilization requirements, and simplify clinical workflows, making them the preferred option for routine vaccinations, therapeutic injections, and large-scale animal health programs. Rising awareness of biosecurity standards and growing demand for convenient, hygienic injection solutions are expected to further strengthen the segment's long-term growth trajectory.
Animal Type Segment Analysis: Companion Animals (Largest & Fastest-Growing Segment)
Holding the largest share of the veterinary injectable devices market, the companion animals segment accounted for 53.42% in 2026 and also represented the fastest-growing category. The increasing rate of pet ownership, higher spending on preventive healthcare, and greater willingness among owners to seek advanced veterinary treatments continue to drive demand for injectable devices. Regular immunization schedules, chronic disease management, and expanding access to specialized veterinary services have further increased the frequency of injectable procedures, reinforcing the segment's dominant and rapidly expanding position.
Material Segment Analysis: Plastic (Largest & Fastest-Growing Segment)
In the veterinary injectable devices market, the plastic segment secured the largest share of 52.26% in 2026 and simultaneously remained the fastest-growing material category. Plastic materials are widely preferred due to their lightweight nature, cost-effectiveness, and compatibility with high-volume manufacturing processes. They also support the production of disposable injection devices that meet modern hygiene and safety standards. Continued innovation in medical-grade polymers and the growing preference for single-use veterinary equipment are expected to sustain the segment's leadership and growth.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Usage | Disposable Devices, Reusable Devices | Disposable Devices | Disposable Devices |
| Animal Type | Companion Animals, Livestock Animals, Others | Companion Animals | Companion Animals |
| Material | Plastic, Metal, Glass, Others | Plastic | Plastic |
| Product | Syringes, Needles, Remote Injectable Devices, Needle Free Injector Systems, Auto-injectors, Others | Syringes | Needle Free Injector Systems |
| End Use | Veterinary Hospitals, Veterinary Clinics, Academic and Research Institutes, Others | Veterinary Hospitals | Veterinary Clinics |
| Clinical Applications | Vaccination and Preventive Care, Anti-infectives, Anesthesia and Analgesia, Fertility and Reproduction, Others | Vaccination and Preventive Care | Vaccination and Preventive Care |
Competitive Landscape and Market Positioning
Key companies in the veterinary injectable devices market:
- Zoetis, Inc. (USA)
- Merck & Co., Inc. (USA)
- Elanco Animal Health Incorporated (USA)
- B. Braun Melsungen AG (Germany)
- Baxter International, Inc. (USA)
- Terumo Corporation (Japan)
- Medtronic plc (Ireland)
- Neogen Corporation (USA)
- Henke-Sass Wolf GmbH (Germany)
- Hamilton Company (USA)
Veterinary injectable devices market competition is becoming increasingly centered on improving precision, safety, and usability across diverse animal healthcare settings. Device manufacturers are moving beyond basic delivery mechanisms by focusing on designs that support more reliable administration, reduced handling challenges, and better adaptation to veterinary workflows. Competitive positioning is also influenced by the ability to address the needs of both large-scale animal care operations and companion animal practices, where ease of use, durability, and consistent performance shape purchasing decisions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (USA) | |||||||
| Merck & Co. Inc. (USA) | |||||||
| Elanco Animal Health Incorporated (USA) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| Baxter International Inc. (USA) | |||||||
| Terumo Corporation (Japan) | |||||||
| Medtronic plc (Ireland) | |||||||
| Neogen Corporation (USA) | |||||||
| Henke-Sass Wolf GmbH (Germany) | |||||||
| Hamilton Company (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| AmacaThera | May-25 | AmacaThera signed a binding evaluation and option agreement with Merck Animal Health to develop long-acting formulations utilizing its proprietary AmacaGel hydrogel platform, aiming to enhance sustained therapeutic delivery with a single injection for veterinary applications. |
| NuGen Medical Devices | Jun-22 | NuGen Medical Devices launched the PetJet, a needle-free injection device engineered specifically for domesticated pets, enabling veterinarians and pet owners to administer various medications safely and rapidly without traditional hypodermic needles. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Injectable Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Procurement Channel | Direct Procurement, Distributors & Wholesalers, Group Purchasing Organizations |
| Price Tier | Economy, Mid-Range, Premium |
| Sterility Configuration | Sterile, Non-Sterile |
Veterinary Injectable Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Value-Based Care Economics |
|
| Payer–Provider Adoption Pathways |
|
| Health Data Integration Landscape |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of veterinary injectable devices?
What is the anticipated CAGR of the veterinary injectable devices industry?
How is pet humanization influencing demand for veterinary injectable devices?
Why is expanding veterinary infrastructure creating growth opportunities for the veterinary injectable devices market?
Why are disposable devices leading the veterinary injectable devices market?
How is the companion animals segment driving market growth for veterinary injectable devices?
What supports North America’s leadership in the veterinary injectable devices market?
Why is Asia Pacific expected to experience the fastest growth in veterinary injectable devices?
Which organizations are considered leaders in the veterinary injectable devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization